[Experimental vasospasms--significance of oxyhemoglobin, fibrin degradation products and breakdown products of white ghost in the pathogenesis of cerebral vasospasms. Treatment of vasospasms with gabexate mesilate and diphenhydramine (author's transl)].
D000818:Animals; D004155:Diphenhydramine / Q000627:therapeutic use*; D004285:Dogs; D005338:Fibrin Fibrinogen Degradation Products; D016670:Gabexate; D006146:Guanidines / Q000627:therapeutic use*; D006242:Haptoglobins / Q000627:therapeutic use; D002546:Ischemic Attack, Transient / Q000139:chemically induced* / Q000188:drug therapy; D010108:Oxyhemoglobins; D013345:Subarachnoid Hemorrhage / Q000473:pathology
D005338:Fibrin Fibrinogen Degradation Products; D006146:Guanidines; D006242:Haptoglobins; D010108:Oxyhemoglobins; D016670:Gabexate; D004155:Diphenhydramine